In focus · trending topic

leukotriene b4

1 stories · following the connections

Celtaxsys announces the issue of four new patents expanding its pipeline of selective leukotriene B4 modulation anti-inflammatory medicines

By Nasdaq OMXFeb 1, 2018, 1:00 PM UTC